Table 2 Effect of probiotic (B. subtilis CU1) and placebo consumption on clinical outcomes of infectious diseases

Mean number of days with CID

5.1

7.0

6.6

7.3

0.2015^a

4.5

7.3

7.3

8.2

0.1101^a

Mean duration of CID (d)

5.0

4.6

5.3

4.1

0.2361^a

5.8

5.6

5.7

4.1

0.2361^a

Mean intensity of CID

8.1

5.0

7.6

4.4

0.7400^a

9.0

6.2

8.8

5.3

0.7400^a

CID frequency

1.0

1.2

1.2

1.2

0.3290^a

0.8

1.0

1.3

1.2

0.1117^a

Subjects with at least one CID

0.4106^b

0.1260^b

  n

 %

Mean number of days with RI

4.4

6.9

6.2

7.2

0.1027^a

3.7

6.9

6.6

7.9

0.0818^a

Mean duration of RI (d)

5.9

5.0

5.6

4.2

0.9043^a

6.8

6.3

6.1

4.3

0.9325^a

Mean intensity of RI

9.3

5.3

7.8

4.6

0.1428^a

11.1

6.3

9.3

5.6

0.3473^a

RI frequency

0.7

0.9

1.1

1.2

0.1181^a

0.6

0.7

1.1

0.9

0.0323 ^a

Subjects with at least one RI

0.1609^b

0.0701^b

  n

 %